Vaxcyte | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

16:47 ET

Vaxcyte | 10-K: Annual report

16:18 ET

Vaxcyte | 8-K: Vaxcyte Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

16:08 ET

Vaxcyte | 4: Statement of changes in beneficial ownership of securities-Officer GUGGENHIME ANDREW

Feb 19 18:06 ET

Vaxcyte | 144: Notice of proposed sale of securities pursuant to Rule 144

Feb 18 16:34 ET

Vaxcyte | SCHEDULE 13G/A: Others

Feb 14 12:15 ET

Vaxcyte | SCHEDULE 13G/A: Others

Feb 12 09:37 ET

Vaxcyte | 4: Statement of changes in beneficial ownership of securities-Officer Eydelman Mikhail

Feb 7 16:05 ET

Vaxcyte | 144: Notice of proposed sale of securities pursuant to Rule 144

Feb 5 16:06 ET

Vaxcyte | 4: Statement of changes in beneficial ownership of securities-Officer Wassil Jim

Feb 4 07:00 ET

Vaxcyte | 144: Notice of proposed sale of securities pursuant to Rule 144

Feb 3 08:43 ET

Vaxcyte | 4: Statement of changes in beneficial ownership of securities-Officer GUGGENHIME ANDREW

Jan 22 18:23 ET

Vaxcyte | 144: Notice of proposed sale of securities pursuant to Rule 144

Jan 21 16:07 ET

Vaxcyte | 4: Statement of changes in beneficial ownership of securities-Director Loxam Teri

Jan 17 16:11 ET

Vaxcyte | 144: Notice of proposed sale of securities pursuant to Rule 144

Jan 15 16:08 ET

Vaxcyte | 4: Statement of changes in beneficial ownership of securities-Officer Eydelman Mikhail

Jan 7 16:34 ET

Vaxcyte | 144: Notice of proposed sale of securities pursuant to Rule 144

Jan 6 16:04 ET

Vaxcyte | 4: Statement of changes in beneficial ownership of securities-Officer Wassil Jim

Jan 3 18:12 ET

Vaxcyte | 144: Notice of proposed sale of securities pursuant to Rule 144

Jan 2 16:12 ET

Vaxcyte | 4: Statement of changes in beneficial ownership of securities-Officer GUGGENHIME ANDREW

Dec 19, 2024 16:09 ET